Experiment: 6TRM

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
2	2D 1H-13C HSQC	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
3	2D 1H-1H NOESY	20 mM [U-100% 2H] acetic acid, 1.5 mM PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
4	2D 1H-1H TOCSY	20 mM [U-100% 2H] acetic acid, 1.5 mM PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
5	3D 1H-15N NOESY	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
11	3D 1H-15N TOCSY	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
10	3D HNHA	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
9	3D HNCA	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
8	3D HN(CO)CA	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
7	3D HNCACB	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
6	3D HN(COCA)CB	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
13	3D HNCO	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
12	3D HN(CA)CO	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
14	3D HCCH-TOCSY	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700
15	3D 1H-13C NOESY aliphatic	20 mM [U-100% 2H] acetic acid, 650 uM [U-100% 13C; U-100% 15N] PAFC, 95 % H2O, 5 % [U-2H] D2O	95% H2O/5% D2O	0.007 M	4.5	1 atm	298	Bruker AVANCE III 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	700

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	TALOS	N	Cornilescu, Delaglio and Bax
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	CcpNmr Analysis	2.4.2	CCPN
4	peak picking	CcpNmr Analysis	2.4.2	CCPN
5	processing	TopSpin	3.1	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.